Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban
Clinical trial NCT02207257 · COMPLETED
Trial details
- NCT number
- NCT02207257
- Sponsor
- Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-09-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.